These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 26039627)
1. E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional Program. Jiang X; Nevins JR; Shats I; Chi JT PLoS One; 2015; 10(6):e0127951. PubMed ID: 26039627 [TBL] [Abstract][Full Text] [Related]
2. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures. Wang Y; Alla V; Goody D; Gupta SK; Spitschak A; Wolkenhauer O; Pützer BM; Engelmann D Nucleic Acids Res; 2016 Jan; 44(1):117-33. PubMed ID: 26350215 [TBL] [Abstract][Full Text] [Related]
6. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation. Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430 [TBL] [Abstract][Full Text] [Related]
7. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Ofir M; Hacohen D; Ginsberg D Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377 [TBL] [Abstract][Full Text] [Related]
8. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Merdzhanova G; Edmond V; De Seranno S; Van den Broeck A; Corcos L; Brambilla C; Brambilla E; Gazzeri S; Eymin B Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759 [TBL] [Abstract][Full Text] [Related]
9. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene. Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789 [TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy. Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383 [TBL] [Abstract][Full Text] [Related]
11. Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library. Li Z; Stanelle J; Leurs C; Hanenberg H; Pützer BM Nucleic Acids Res; 2005; 33(9):2813-21. PubMed ID: 15897325 [TBL] [Abstract][Full Text] [Related]
12. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells. Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347 [TBL] [Abstract][Full Text] [Related]
13. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982 [TBL] [Abstract][Full Text] [Related]
14. [The Influence of the Minor Short Isoform of Securin (PTTG1) on Transcription is Significantly Different from the Impact of the Full Isoform]. Demin DE; Uvarova AN; Klepikova AV; Schwartz AM Mol Biol (Mosk); 2020; 54(1):51-59. PubMed ID: 32163388 [TBL] [Abstract][Full Text] [Related]
15. The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis. Lu H; Hallstrom TC J Biol Chem; 2013 Aug; 288(33):23833-43. PubMed ID: 23833190 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the MDR1 promoter by E2F1 and EAPP. Andorfer P; Rotheneder H FEBS Lett; 2013 May; 587(10):1504-9. PubMed ID: 23542036 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells. Islam MS; Tatsumi Y; Takano R; Yokochi T; Akter J; Ozaki T; Nakamura Y; Ohira M; Nakagawara A Biochem Biophys Res Commun; 2016 Sep; 478(1):81-86. PubMed ID: 27453342 [TBL] [Abstract][Full Text] [Related]
18. Roles of E2F1 in mesangial cell proliferation in vitro. Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784 [TBL] [Abstract][Full Text] [Related]
19. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Hallstrom TC; Nevins JR Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10848-53. PubMed ID: 12954980 [TBL] [Abstract][Full Text] [Related]
20. E2F1 regulates autophagy and the transcription of autophagy genes. Polager S; Ofir M; Ginsberg D Oncogene; 2008 Aug; 27(35):4860-4. PubMed ID: 18408756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]